Weighted Average Number of Shares Outstanding, Basic of Bioventus Inc. from 03 Apr 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bioventus Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 03 Apr 2021 to 31 Dec 2025.
  • Bioventus Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 66,622,631, a 3.2% increase year-over-year.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 66,622,631, a 3.2% increase from 2024.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 64,547,474, a 3% increase from 2023.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 62,647,554, a 2% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Bioventus Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 66,622,631 +2,075,157 +3.2% 28 Sep 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 66,924,682 +1,666,255 +2.6% 29 Jun 2025 27 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 66,500,433 +2,443,674 +3.8% 30 Mar 2025 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 66,008,683 +2,628,496 +4.1% 01 Jan 2025 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 64,547,474 +1,899,920 +3% 29 Sep 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 65,258,427 +2,434,109 +3.9% 30 Jun 2024 28 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 64,056,759 +1,505,474 +2.4% 31 Mar 2024 29 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 63,380,187 +1,255,435 +2% 01 Jan 2024 30 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 62,647,554 +1,258,447 +2% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
Q3 2023 62,824,318 +1,150,064 +1.9% 02 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 62,551,285 +1,075,935 +1.8% 02 Apr 2023 01 Jul 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 62,124,752 +1,639,783 +2.7% 01 Jan 2023 01 Apr 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 61,389,107 +15,916,624 +35% 02 Oct 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
Q3 2022 61,674,254 +19,836,673 +47% 03 Jul 2022 01 Oct 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 61,475,350 +19,670,003 +47% 03 Apr 2022 02 Jul 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 60,484,969 +18,687,087 +45% 01 Jan 2022 02 Apr 2022 10-Q 16 May 2023 2023 Q1
Q4 2021 45,472,483 03 Oct 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
Q3 2021 41,837,581 04 Jul 2021 02 Oct 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 41,805,347 04 Apr 2021 03 Jul 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 41,797,882 01 Jan 2021 03 Apr 2021 10-Q 11 May 2022 2022 Q1

Bioventus Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 66,622,631 +2,075,157 +3.2% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 64,547,474 +1,899,920 +3% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 62,647,554 +1,258,447 +2% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
2022 61,389,107 +15,916,624 +35% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 45,472,483 01 Jan 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.